$ALM

Almonty Industries Reports Second Quarter 2026 Financial Results

Almonty Industries (Nasdaq: ALM) reported Q2 2026 results: revenue rose 498% year over year to $43.0 million, with net income of $181.8 million and adjusted EBITDA of $17.6 million. The company closed an oversubscribed $800 million 2.25% convertible notes offering and reported $1.2 billion cash at June 30, 2026. It also amended its GTP offtake agreement, extending it 6 years and raising volumes and pricing.

Original reporting
Published Aug 11, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Almonty Industries Reports Second Quarter 2026 Financial Results — source image
Decision brief

The 30-second read

$ALMBullishMed
01

Why it matters

Q2 2026 results show a step-change in revenue and operating income, while the $800M oversubscribed convertible notes and $1.2B cash position reduce near-term financing risk. The GTP offtake amendment extends contract duration, increases volumes, and improves pricing, which can stabilize revenue visibility as Sangdong ramps.

02

Market read

Traders can reassess near-term valuation drivers using the combination of a strong quarter, a large balance-sheet upgrade, and improved offtake economics.

03

What to watch

Key sensitivities remain tungsten APT pricing and commissioning/ramp-up milestones for Sangdong Phase I, plus execution risk for Phase II and other projects funded by the new cash balance.

Relevance 8/10Novelty 8/10Timing: post-market release of Q2 2026 results (published 2026-08-11 22:00 UTC)

Background

Almonty is a tungsten concentrate producer with the Sangdong Mine in South Korea as a major growth driver, and it has been expanding its development pipeline.

Company-level read

Ticker impact

$ALMBullishMedium confidence
Context

Almonty reported Q2 2026 results with revenue up 498% to $43.0M, plus an oversubscribed $800M convertible notes close and a GTP offtake amendment.

Expected impact

Near-term bias positive, with follow-through risk tied to tungsten pricing and Sangdong ramp-up execution.

Evidence & confidence

The article discloses both an earnings datapoint (revenue, operating income, adjusted EBITDA) and fresh capital structure news (oversubscribed $800M converts, cash up to $1.2B) plus improved offtake terms.

Market effects

Tungsten supply-chain names may see read-across interest as pricing strength and offtake term improvements highlight demand for secure Western-aligned supply.

South Korea mining ramp-up progress at Sangdong could influence sentiment around regional critical-minerals development timelines.

Improved tungsten concentrate pricing and longer offtake duration can reinforce the broader critical-metals narrative tied to defense and advanced technology supply security.

Counterpoint

Reported net income is heavily influenced by non-cash IFRS revaluation gains on derivatives and warrants, so cash earnings power may be less dramatic than headline profit suggests.

Key entities

  • Almonty Industries Inc.

    Nasdaq-listed tungsten concentrate producer reporting Q2 2026 financial results and capital/offtake updates.

  • Global Tungsten & Powders LLC (GTP)

    Offtake partner whose agreement was amended to extend term, increase volumes, and improve pricing for Sangdong Phase I concentrate.

  • Russell 1000 and Russell 3000

    Almonty’s inclusion following the 2026 reconstitution, potentially supporting incremental passive demand.

Related articles

$BMMMed

The Critical Metal at the Center of America’s Next Supply-Chain Crisis

The article says tungsten has outperformed gold, silver and copper over the past year and that the U.S. has not mined tungsten since 2015, while China supplies about 80% of global tungsten and nearly 90% of processing. It notes a U.S. defense rule from Jan 1, 2027 banning tungsten routed through China. It highlights Blue Moon Metals (TSXV: MOON, NASDAQ: BMM) acquiring 33 tungsten and antimony projects near its Springer complex, with consideration including 2.8M shares, $5.0M cash, and a 1% NSR r

$ALMMed

Almonty Industries: A 490-Million-Dollar Contract Offers Ballast as the Stock Tests Key Support

Almonty Industries’ shares fell to C$18.81, down 5.52% on Friday and about 44% below its April 52-week high, as the stock tests support near C$18.00. The company began processing at its Sangdong mine in South Korea and extended an offtake with Global Tungsten & Powders for 21 years, with higher volumes and prices, expected to add at least US$30m annual contract revenue and about US$490m total.

$ALMMed

Almonty Industries Navigates a Pivotal Week: Production Milestones Meet Exchange Overhaul

Almonty Industries said it will delist from the Toronto Stock Exchange after July 31 and from the ASX after CHESS depositary interests end Aug. 28, with ASX delisting effective Sept. 1, citing low Australian volumes. Shares closed C$18.81, down 5.52% on Friday. Sangdong processing began July 1, and a 21-year offtake with Global Tungsten & Powders was expanded by 40% to about US$490 million potential revenue.

$ALMMed

Why is Almirall stock rallying today? By Investing.com

Almirall shares rose 3.5% to €11.45 after the company reported first-half 2026 results. EBITDA increased 23.7% year-on-year to €150.7 million and net sales rose 7.5% to €602.7 million, with biologics Ebglyss and Ilumetri driving growth. Management reiterated 2026 guidance (net sales +9–12%, EBITDA €270–290m). Net income slightly missed consensus.

Almonty Industries Reports Second Quarter 2026 Financial Results — alphai